Prof. Zhang Minghui (CANCER) – We are the World

Cancer erodes not only the body but also one’s confidence, and it steals the hope life once held.
Are the daily treatments and constant worries leaving you physically and emotionally exhausted?
? Traditional treatments present immense challenges -true hope lies in precise and fundamental revolutionary care.

【Global Breakthrough in Cancer Immunotherapy: vNKT Cell Technology]

Prof. Zhang Minghui, Tsinghua University

Chief Investigator, Tsinghua Medical Center | Inventor of vNKT Cell Technology.
Founder of Lehe New Medicine Clinic | Director of Chronic Disease Center, Boshan Hospital of Traditional Chinese Medicine.
Lead Researcher of Clinical Projects at Shanghai Changhai Hospital & Eastern Hepatobiliary
Surgery Hospital.
Health Knowledge Translator”: Bridging science and public understanding of health
innovation.

Revolutionary Technology: vNKT Cell Immunotherapy

Pioneered large-scale expansion of vNKT cells: 10x more potent than natural killer (NK) cells
Discovered dendritic cell proliferation and redifferentiation mechanisms: Led China’s first dendritic cell-based drug (completed Phase IIclinical trials).
Dual anti-tumor effects: Broad-spectrum targeting of solid tumors + activation of long-term
immune memory.

Clinical Results (2010-2025 | Nearly 1,000 Patients)

Stage III Cancer: 90% clinical cure rate (5-year tumor-free survival).
Stage IV Cancer: 80% overall response rate.
dvanced Liver/Lung Metastasis: 20% clinical cure rate (gastrointestinal & hepatobiliary tumors).
5+types of solid tumors treated (including liver, lung, pancreatic, breast, and more).

Session Highlights

Open collaboration opportunities for patients and institutions.
Insights into cutting-edge immunotherapy trends and real-world case studies.

Who Should Attend?

Cancer patients and families.
Oncologists, researchers, and medical students.
Biotech and healthcare organization representative.
Health media professionals and content creators.

Redefining the boundaries of life through science

A new hope for cancer treatment in Asia

Session Includes

120-min talk + Q&A with Prof. Zhang and team
November 9, 2:30 PM.
120-minute seminar on the latest cancer treatment trends (with other experts)
November 10, 2:30 AM.
.30-min exclusive media interviews (upon request)

We Invite:

Global patients and families, medical professionals, students, researchers, and media interested in innovative cancer therapies.

Let’s join forces to bring hope to cancer patients across Asia.

Register Now (Limited Seat)

Note: Clinical data based on research led by Prof. Zhang Minghui. Individual results may vary.